PTP-01

BIOLOGICAL2 trials

Sponsors

University of Virginia, Doron Therapeutics Inc.

Conditions

Knee OsteoarthritisPancreatic Ductal Adenocarcinoma

Early Phase 1

Phase 0 Biodistribution of Novel Imaging for Resectable Pancreatic Cancer

TerminatedNCT01962909

University of VirginiaPancreatic Ductal Adenocarcinoma

Start: 2013-11-30End: 2016-01-31Updated: 2016-03-18

Phase 3

A Study to Evaluate the Efficacy and Safey of PTP-001 (MOTYS™) in Knee Osteoarthritis Patients

RecruitingNCT07219771

Doron Therapeutics Inc.Knee Osteoarthritis

Start: 2025-10-14End: 2027-10-01Target: 260Updated: 2026-04-29

Related Papers

Abstract 6299: ZB131 antibody-drug conjugates induce potent antitumor activity

Cancer Research2023-04-04